- Forums
- ASX - By Stock
- [INTERVIEW] Recce Pharmaceuticals accelerates commercialisation with positive Phase II results
RCE
recce pharmaceuticals ltd
Add to My Watchlist
1.14%
!
44.5¢

Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
44.5¢ |
Change
0.005(1.14%) |
Mkt cap ! $127.2M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 44.5¢ | $3.231K | 7.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2785 | 44.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10045 | 0.445 |
2 | 15937 | 0.440 |
3 | 60000 | 0.430 |
5 | 48432 | 0.415 |
2 | 11050 | 0.410 |
Price($) | Vol. | No. |
---|---|---|
0.435 | 13 | 1 |
0.445 | 7247 | 2 |
0.450 | 30000 | 1 |
0.500 | 7000 | 1 |
0.515 | 10000 | 1 |
Last trade - 09.59am 11/09/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
EVR
EV RESOURCES LTD
Shane Menere, Non-Executive Chairman
Shane Menere
Non-Executive Chairman
SPONSORED BY The Market Online